Professor Gazzard was voted in the World’s Top 10 Most Influential Ophthalmologists in April 2022.
Professor Gazzard’s paper was voted the 11th most impactful Glaucoma research paper ever.
From the “The American Glaucoma Society 100 Articles with Significant Impact on Clinical Glaucoma”
You can read the full list of selected articles here (PDF download)
Article featuring Professor Gus Gazzard’s work on SLT and the LiGHT Study
“Glaucoma researchers deliver verdict on SLT versus eye drops in LiGHT study”
You can read more and the full article here
Article featuring Professor Gus Gazzard’s research “How Surgery Plus Stent Slows Glaucoma Progression Better Than Surgery Alone — Five-year follow-up shows significantly less annual visual field progression with the stent”
You can read more and the full article here
Gus’s paper was selected to be European Glaucoma Society ‘Clinical Paper of the Month’ for January 2023
Professor Gazzard was interviewed by the American Society of Cataract and Refractive Surgery on the Ophthamalogy podcast on the efficacy of repeat SLT.
- Free mobile app demystifies GlaucomaArticle about a free mobile app that demystifies glaucoma – helping to explain symptoms, impact and treatment to patients and their families. You can read the full article here
- China SLT Webinar 21 Feb 2023Gus Gazzard lecture on SLT to over a thousand ophthamalogists in China on 21 February 23 China SLT Webinar 21 Feb 2023
- LiGHT: Efficacy and Cost Effectiveness – Eyetube VideoSarwat Salim, MD, FACS, sits down with Gus Gazzard, MD, FRCOphth, to discuss the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. Dr. Gazzard details the study design, efficacy data, and cost effectiveness of selective laser trabeculoplasty versus medication. You can read more and see a preview video here
- Ophthamalogy Times Europe: ‘LIGHT Trial focuses on lowering IOP, keeping it there’Professor Gazzard’s work is covered in this piece from November 2019 published in the Ophthamalogy Times Europe magazine. You can read the full article here
- NIHR: Professor Gus Gazzard publishes ground-breaking researchThe National Institute for Health Research (NIHR) Dissemination Centre has published an NIHR Signal on Professor Gazzard’s research. You can read the Signal here: A laser eye procedure can be effective and safe if used early as a treatment for glaucoma
- The Lancet: Laser trabeculoplasty as first-line glaucoma treatmentThe prestigious medical journal The Lancet published results from a pioneering research study, funded by the National Institute of Health Research (NIHR) and led by Professor Gus Gazzard. Read the article published in The Lancet here
- The Daily Mail: Patient Experience with Glaucoma DiagnosisAn article from the Daily Mail about glaucoma surgery that quotes Professor Gazzard. You can read the article here
- The Daily Mail: “A laser could end the inconvenience of eye drops for glaucoma”Guy Staniforth, 62, a project engineer from Greenwich in South-East London, describes having a glaucoma operation with Professor Gazzard. You can read the full article here
- Positive effects of Hydrus plus phaco persistPARIS — The HORIZON trial at 3 years demonstrated that the Hydrus Schlemm’s canal stent added sustained IOP lowering to that achieved by cataract surgery alone, Gus Gazzard, MD, MBBChir, FRCOphth, said at the European Society of Cataract and Refractive Surgeons meeting. “That intraocular pressure was stable, significantly better than control after 3 years,” Gazzard said. Read the full article here
- UCL Institute of Ophthalmology: Gus Gazzard appointed Professor of Glaucoma StudiesSpeaking of his promotion and clinical trials, Gus said: “I am honoured to have been appointed to a UCL Professorship and I look forward to further developing the clinical trials and excellent postgraduate clinical education that we have established here at the UCL Institute of Ophthalmology. The clinical trials that I work on across the globe are a testament to the great team that I’ve been able to build at the Institute of Ophthalmology and Moorfields Eye Hospital, and a tribute to all of their hard work – the energy they bring to answer questions of real clinical importance to patients with blinding diseases.” You can read more here
- The Ophthalmologist: “Time to Transform Glaucoma Treatment Paradigm”SLT is an effective intervention for newly-diagnosed patients – and now we can prove it. This is an article about the research conducted by Professor Gazzard. Read The Ophthalmologist article here
- The Guardian: “15 Minute Laser Treatment Best For Glaucoma Patients”Lasers should become the principal method in the UK for treating patients with the debilitating eye condition glaucoma. That is the stark conclusion of a three-year study published recently. Read the full article in The Guardian here
- NHS NATIONAL SILVER MERIT AWARD WINNERGus has been awarded the prestigious, competitively awarded “NHS National Silver Merit Award”. These awards recognise NHS consultants who perform ‘over and above’ the standard expected of their role.
- FLIPBOOK by Moorfields Eye Charity Magazine Features Gus GazzardThe Moorfields Eye Charity Flipbook magazine has a feature articles on Professor Gazzard’s innovative research. You can read the Flipbook feature here
- Professor Gazzard now performs the innovative Hydrus Stent ProcedureProfessor Gazzard is now one of only three surgeons performing the innovative Hydrus stent procedure in the UK. Read more about the Hydrus procedure here or download a PDF about Hydrus here
- Professor Gazzard authors ‘Definitive Review of Data’Professor Gus Gazzard is the author of this definitive review of the data on the main treatment for angle closure glaucoma. You can read more about his ground-breaking research here
- NICE Report on Trabecular Stent Bypass MicrosurgeryNICE (National Institute for Health and Care Excellence) have released a report on Trabecular stent bypass microsurgery for open-angle glaucoma You can read the full, positive report here.
- OPTOMETRY TODAY article: Gus Gazzard On Selective Laser TrabeculoplastyThe Moorfields Glaucoma Service Director Professor Gus Gazzard discusses a non-invasive glaucoma treatment that could reduce the need for eye drops. Includes a 7 minute video interview with Professor Gazzard by Optometry Today. Read the Optometry Today article and watch the video here
- DAILY MAIL: Me and My Operation: Laser for glaucoma, a painless blast of light to stop you going blind“A laser could end the inconvenience of eye drops for glaucoma” – Article in the Daily Mail 26.08.19 Guy Staniforth, 62, a project engineer from Greenwich in South-East London, tells ADRIAN MONTI about having the operation by Professor Gazzard. You can read the full article here
- interview on radio 4Listen to an interview with Professor Gazzard on BBC Radio 4 https://www.bbc.co.uk/programmes/m000mt1n